A Survey of the Use of Herbs Among Patients Attending Secondary-Level Health Care Facilities in Southwestern Nigeria

REFERENCES

• May F E, Stewart R B, Cliff L E. Drug interactions and multiple drug administration. Clin Pharmacol Ther 1977; 22: 322
   PubMed Web of Science ®Google Scholar
• Ledwidge M, Travers B, Ryder M, Ryan E, McDonald K. Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug interactions. Eur J Heart Fail 2004; 6(2)235–43, doi: 10:1016/j.ejheart.20003.08.003
   PubMed Web of Science ®Google Scholar
• Karas S, Jr. The potential for drug interactions. Ann Emerg Med 1981; 10: 627–30
   PubMed Web of Science ®Google Scholar
• Haase G, Pietzsch M, Fahnrich A, Voss W, Riethling A K. Results of a systematic adverse drug reaction (ADR)-screening concerning bradycardia caused by drug interactions in departments of internal medicine in Rostock. Int J Clin Pharmacol Ther 2002; 40(3)116–9
   PubMed Web of Science ®Google Scholar
• Kohler G I, Bode-Boger S M, Busse R, Hoopmann M, Welte T, Boger R H. Drug–drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 2000; 38(11)504–13
   PubMed Web of Science ®Google Scholar
• Yamreudeewong W, De Bisschop M, Martin L G, Lower D L. Potentially significant drug interactions of class III antiarrhythmic drugs. Drug Saf 2003; 26(6)421–38
   PubMed Web of Science ®Google Scholar
• Niemi M, Backman J T, Fromm M F, Neuvonen P J, Kivisto K T. Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet 2003; 42(9)819–50
   PubMed Web of Science ®Google Scholar
• Puckett W H, Jr, Visconti J A. An epidemiological study of the clinical significance of drug-drug interactions in a private community hospital. Am J Hosp Pharm 1971; 28(4)247–53
   PubMedGoogle Scholar
• Stanton L A, Peterson G M, Rumble R H, Cooper G M, Polack A R. Drug-related admissions to an Australian hospital. J Clin Pharmacol Ther 1994; 19: 341–7
   PubMed Web of Science ®Google Scholar
• Classen D C, Pestotnik S L, Evans R S, Lloyd J F, Burke J P. Adverse drug events in hospitalized patients. J Am Med Assoc 1997; 277: 301–6
   PubMed Web of Science ®Google Scholar
• Lazarou J, Pomeranz B, Corey P N. Incidence of adverse drug reactions in hospitalized patients: a meta analysis of prospective studies. J Am Med Assoc 1998; 279: 1200–5
   PubMed Web of Science ®Google Scholar
• Zhou S, Chan E, Pan S Q, Huang M, Lee E J. Pharmacokinetic interactions of drug with St. John's wort. J Psychopharmacol 2004; 18(2)262–76, doi: 10.1177/0269881104042632
   PubMed Web of Science ®Google Scholar
• Drew A K, Myers S P. Safety issues in herbal medicine: implications for health professions. Med J Aust 1997; 166: 538–41
   PubMed Web of Science ®Google Scholar
• Mai I, Knuger H, Budde K, et al. Hazardous pharmacokinetics interaction of St. Johns' wort (Hypericum perforatum) with immunosuppressant cyclosporine. Int J Clin Pharmacol Ther 2000; 38: 500–2
   PubMed Web of Science ®Google Scholar
• Guengerich F P. Role of cytochrome P450 enzymes in drug–drug interactions. Drug–drug interactions: scientific and regulatory perspectives, A P Li. Academic Press, San Diego 1997; 7–35
   Google Scholar
• Michalets E L. Update: clinically significant cytochrome P450 drug interactions. Pharmacother 1998; 18: 84–112
   PubMed Web of Science ®Google Scholar
• Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements: a five year toxicological study (1991–1995). Drug Saf 1997; 17: 342–56
   PubMed Web of Science ®Google Scholar
• Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 1997; 336: 1108
   PubMed Web of Science ®Google Scholar
• Matthews M K, Jr. Association of Ginkgo biloba with intracerebral hemorrhage. Neurology 1998; 50: 1933
   PubMed Web of Science ®Google Scholar
• Janetzky K, Morreale A P. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 1997; 54: 692–3
   PubMed Web of Science ®Google Scholar
• Johne A, Brockmöller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St. John wort (Hypericum perforatum). Clin Pharmacol Ther 1999; 66: 338–45
   PubMed Web of Science ®Google Scholar
• Maurer A, Johne A, Bauer S, et al. Interaction of St John's wort extract with phenprocoumon. Eur J Clin Pharm 1999; 55: A22
   Google Scholar
• Ruschitzka F, Meier P J, Turina M, Luscher T F, Noll G. Acute heart transplant rejection due to St. Johns' wort. Lancet 2000; 355: 548–549, doi: 10:1016/S0140-6736(99)05467–7
   PubMed Web of Science ®Google Scholar
• Barone G W, By Gurley, Ketel B L, Abul-Ezz S R. Herbal supplements: a potential for drug interactions in transplant recipients. Transplantation 2001; 71: 239–41
   PubMed Web of Science ®Google Scholar
• Durr D, Stieger B, Kullak-Ublick G A, et al. St. John's wort induces intestinal P-glycoprotein/MDR I and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 2000; 68: 598–604, doi: 10:1067/mcp.2000.112240
   PubMed Web of Science ®Google Scholar
• Markowitz J S, De Vane C L, Boulton D W, Carson S W, Nahas Z, Risch S C. Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Life Sci 2000; 66: PL133–9, doi: 10:1016/S0024-3205(99)00659–1
   PubMed Web of Science ®Google Scholar
• Roby C A, Anderson G D, Kantor E, Dnyer D A, Burstein A H. St John's wort—effect on CYP3A4 activity. Clin Pharmacol Ther 2000; 67: 451–7, doi: 10.1067/mcp.2000.106793
   PubMed Web of Science ®Google Scholar
• Fugh-Berman A, Ernst E. Herb–drug interaction: review and assessment of report reliability. Br J Clin Pharmacol 2001; 52: 587–95, doi: 10:1046/j.0306-5251.2001.01469.x
   PubMed Web of Science ®Google Scholar
• Izzo A A, Ernst E. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 2001; 61: 2163–75
   PubMed Web of Science ®Google Scholar
• Shinozuka K, Umegaki K, Kubota Y, et al. Feeding of Gingko biloba extract (GBE) enhance gene expression of hepatic cytochrome P-450 and attenuates the hypotensive effect of nicardipine in rats. Life Sci 2002; 70: 2783–92, doi:10.1016/S0024-3205(02)01530–8
   PubMed Web of Science ®Google Scholar
• Jiang X, Williams K M, Liauw W S, et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharm 2004; 57(5)592–9, doi:10.1111/j.1365-2125.2003.02051
   PubMed Web of Science ®Google Scholar
• Nose M, Tamura M, Ryu N, Mizukami H, Ogihara Y. Sho-saiko-to and saiko-keishi-to, the traditional Chinese and Japanese herbal medicines, altered hepatic drug-metabolizing enzymes in mice and rats when administered orally for a long time. J Pharm Pharmacol 2003; 55: 1419–26, doi:10.1211/0022357021873
   PubMed Web of Science ®Google Scholar
• Foster B C, Foster M S, Vandenhoek S, et al. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J Pharm Pharm Sci 2001; 4(2)176–84
   PubMed Web of Science ®Google Scholar
• Ho P C, Ghose K, Saville D, Wanwimolruk S. Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers. Eur J Clin Pharm 2000; 56(9–10)693–8
   PubMed Web of Science ®Google Scholar
• Lane H Y, Jann M W, Chang Y C, et al. Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability. J Clin Psychol 2001; 62(10)812–7
   Web of Science ®Google Scholar
• Tassaneeyakul W, Vannaprasaht S, Yamazoe Y. Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice. Br J Clin Pharm 2001; 49920: 139–44, doi:10.1046/j.1365–2125.2000.00122.x
   Google Scholar
• Chen L, Mohr S N, Yang C S. Decrease of plasma and urinary oxidative metabolites of acetaminophen after consumption of watercress by human volunteers. Clin Pharm Ther 1996; 60(6)651–60
   PubMed Web of Science ®Google Scholar
• Fugh-Berman A. Herb–drug interactions. Lancet 2000; 355: 134–8, doi:10.1016/ S0140-6736(99)06457-0
   PubMed Web of Science ®Google Scholar
• Horn J R, Hansten P D. Drug Interactions: insights and observations—hyperkalaemia due to drug interactions. Pharm Times January, 2004; 66–7
   Google Scholar
• Kuo G M, Hawley S T, Weiss L T, Balkrishnan R, Volk R J. Factors associated with herbal use among urban multiethnic primary care patients: a cross-sectional survey. BMC Complement Altern Med 2004; 4: 18, doi:10.1186/1472–6882–4–18
   PubMedGoogle Scholar
• Richard Ko. Adverse reactions to watch for in patients using herbal remedies. West J Med 1999; 171(3)181–6
   PubMedGoogle Scholar
• Kolawole J A, Maduenyi A. Effect of zobo (Hibiscus sabdariffa water extract) on the pharmacokinetics of acetaminophen in human volunteers. Eur J Drug Metab Pharmacokinet 2004; 29(1)25–9
   PubMed Web of Science ®Google Scholar
• Saxena A K, Panholta B R. Herbal remedies—renal tragedies. Swiss Med Wkly 2003; 133: 188–9
   PubMed Web of Science ®Google Scholar
• Giveon S M, Liberman N, Klang S, Kahan E. A survey of primary care physicians' perceptions of their patients' use of complimentary medicine. Complement Ther Med 2003; 11(4)254–60, doi: 10.1016/S0965–2299(03)00114–6
   PubMed Web of Science ®Google Scholar